Xiao-Jing Li

Discovery of a cinnamyl piperidine derivative as new neddylation inhibitor for gastric cancer treatment.

Hong-min Liu, Bo Wang, Qiuju Zhang, 2021, European journal of medicinal chemistry.

Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5- a]pyrimidine-Based Inhibitors Targeting the DCN1-UBC12 Protein-Protein Interaction.

Lina Ding, Linlin Yang, Xiao-Jing Shi, 2019, Journal of medicinal chemistry.

Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1

Hong-min Liu, Xiao-Jing Li, Kaizhao Hu, 2021, Scientific reports.

Discovery of tofacitinib derivatives as orally active antitumor agents based on the scaffold hybridization strategy.

Xiao-Jing Shi, Hong-min Liu, Xiao-Jing Li, 2020, European journal of medicinal chemistry.

The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers

Sumei Wang, Xiao-Jing Li, Wanyin Wu, 2022, Frontiers in Immunology.

Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1

Xiao-Jing Shi, Hong-min Liu, Xiao-Jing Li, 2021, Scientific Reports.